UBS Group’s Outset Medical OM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Buy |
79,586
+67,485
| +558% | +$1.3M | ﹤0.01% | 4038 |
|
|
2025
Q1 | $134K | Buy |
12,101
+5,974
| +98% | +$66.1K | ﹤0.01% | 5562 |
|
|
2024
Q4 | $102K | Buy |
6,127
+5,883
| +2,411% | +$98K | ﹤0.01% | 5647 |
|
|
2024
Q3 | $2.48K | Buy |
244
+163
| +201% | +$1.66K | ﹤0.01% | 7204 |
|
|
2024
Q2 | $4.65K | Sell |
81
-3,388
| -98% | -$195K | ﹤0.01% | 6907 |
|
|
2024
Q1 | $116K | Buy |
3,469
+2,647
| +322% | +$88.2K | ﹤0.01% | 5005 |
|
|
2023
Q4 | $66.7K | Buy |
822
+566
| +221% | +$46K | ﹤0.01% | 5195 |
|
|
2023
Q3 | $41.8K | Sell |
256
-1,574
| -86% | -$257K | ﹤0.01% | 5285 |
|
|
2023
Q2 | $600K | Buy |
1,830
+67
| +4% | +$22K | ﹤0.01% | 3684 |
|
|
2023
Q1 | $487K | Buy |
1,763
+1,465
| +492% | +$404K | ﹤0.01% | 3728 |
|
|
2022
Q4 | $115K | Buy |
298
+16
| +6% | +$6.2K | ﹤0.01% | 4853 |
|
|
2022
Q3 | $68K | Sell |
282
-6,293
| -96% | -$1.52M | ﹤0.01% | 4997 |
|
|
2022
Q2 | $1.47M | Buy |
6,575
+6,475
| +6,475% | +$1.44M | ﹤0.01% | 2598 |
|
|
2022
Q1 | $68K | Sell |
100
-812
| -89% | -$552K | ﹤0.01% | 5187 |
|
|
2021
Q4 | $631K | Buy |
912
+576
| +171% | +$399K | ﹤0.01% | 3804 |
|
|
2021
Q3 | $249K | Buy |
336
+189
| +129% | +$140K | ﹤0.01% | 4138 |
|
|
2021
Q2 | $111K | Sell |
147
-147
| -50% | -$111K | ﹤0.01% | 4764 |
|
|
2021
Q1 | $240K | Buy |
294
+122
| +71% | +$99.6K | ﹤0.01% | 4391 |
|
|
2020
Q4 | $146K | Buy |
172
+136
| +378% | +$115K | ﹤0.01% | 4473 |
|
|
2020
Q3 | $27K | Buy |
+36
| New | +$27K | ﹤0.01% | 5218 |
|